Ignite Creation Date:
2025-12-24 @ 1:38 PM
Ignite Modification Date:
2025-12-30 @ 7:48 AM
Study NCT ID:
NCT05599295
Status:
COMPLETED
Last Update Posted:
2025-11-25
First Post:
2022-10-20
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Study to Evaluate the Safety of Intravenous Oritavancin for the Treatment of Children With Skin Infections
Sponsor:
Melinta Therapeutics, LLC
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
ML-ORI-201
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None